TRAVERE THERAPEUTICS INC (TVTX)

US89422G1076 - Common Stock

5.26  -0.13 (-2.41%)

After market: 5.26 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
145.24M212.00M227.50M198.30M175.30M
Cost Of Goods
11.45M7.60M6.80M6.10M5.20M
Gross Profit
133.79M204.40M220.70M192.20M170.10M
Operating Expenses
510.53M471.00M382.50M271.30M285.00M
Research and Development
237.73M229.50M209.20M130.60M139.80M
Selling, General, and Administrative Expenses
236.52M195.50M126.10M114.50M110.40M
Operating Income
-376.74M-266.50M-161.80M-79.10M-114.90M
Interest Income/Expense
10.43M-5.00M-18.10M-14.00M-8.80M
Other Income/Expense
1.59M1.00M200.00K1.40M-300.00K
Non Recurring Items
-11.39M-7.60MN/A-97.10M-22.50M
Income Before Taxes
-376.11M-278.20M-179.70M-188.80M-146.40M
Income Tax
223.00K300.00K400.00K0.000.00
Net Income
-111.40M-278.50M-180.10M-169.40M-146.40M
EBITDA
-338.21M-233.42M-135.18M-54.52M-94.49M
 
Per Share Data
EPS Diluted Total Ops
-1.49-4.37-3.01-3.56-3.46
Non GAAP EPS
-4.60-4.37-3.03-1.48-2.98
 
Statistics
Gross Profit Margin
92.12%96.42%97.01%96.92%97.03%
Profit Margin
-76.70%-131.37%-79.16%-85.43%-83.51%
Operating Profit Margin
-259.40%-125.71%-71.12%-39.89%-65.54%

All data in USD

Charts